Oncolytics Biotech announced data from a Phase 1b/2 trial showing pelareorep, combined with other therapies, activates antiviral immune responses and remodels the tumor environment in relapsed/refractory multiple myeloma patients. The treatment enhanced T cell activity and induced tumor cell apoptosis, suggesting potential as an effective immunotherapy. These findings support further development of pelareorep in combination with immune-based treatments for cancer.
Pelareorep in multiple myeloma offers context for health sector stocks on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 09, 2026 20:42 WIB: Out of 150 priced US health stocks, 110 rose and 27 fell. Notable movers include INO at USD 1.33 (+9.47%), ARWR at USD 53.74 (-7.59%), and FLNA at USD 0.48 (+6.01%). Typical hold times range from 24 to 41 days.
Neo Security, Inc. has launched Neoverse, a free AI software intelligence engine that researches and classifies over 4 million AI apps, extensions, and servers to assess their capabilities and security risks. Integrated into Neo's platform, Neoverse ...
AnorTech Inc. completed a $7.55 million share exchange with Nasdaq-listed Greenland Mines, increasing Greenland Mines' ownership in AnorTech to 19.9%. Greenland Mines acquired over 25 million AnorTech shares in exchange for Greenland Mines shares val...
Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...
Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...
